Status of mammography after the Digital Mammography Imaging Screening Trial: digital versus film

The Breast Journal
D D Dershaw

Abstract

Well-publicized results of the recent Digital Mammography Imaging Screening Trial (DMIST) have again shown that there is no clear advantage in mammographic screening of the general population with digital versus film mammography. However, several subgroups--women less than 50 years old, pre- or perimenopausal, and denser breasts--did better with digital mammography than with film. Data also suggest that women with the opposite characteristics might do better with film mammography. This article reviews the data of the four studies comparing digital and film mammographic screening. In addition, it describes the technology involved in the two types of mammographic image capture, the advantages and disadvantages of each type of imaging, and the future possibilities opened by digital technique. Because less than one-tenth of mammography units in use in the United States are digital, the availability of this technology to women undergoing screening and to physicians referring patients to screening sites is very limited. The author suggests that the quality of mammography, rather than the technique used to capture the image, is more important in selecting a mammography facility. For those who have a facility that offers both digital a...Continue Reading

References

Jul 26, 2003·Radiology·Roberta A JongDonald B Plewes
Nov 13, 2004·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Mahadevappa Mahesh
Sep 20, 2005·The New England Journal of Medicine·Etta D PisanoUNKNOWN Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group
Oct 28, 2005·The New England Journal of Medicine·D David Dershaw
Apr 7, 2007·Journal of the American College of Radiology : JACR·Jay Parikh

❮ Previous
Next ❯

Citations

Aug 9, 2003·Medical Physics·Alan H BaydushCarey E Floyd
Mar 26, 2005·Medical Physics·Hans Bornefalk, Anna Bornefalk Hermansson
Jul 29, 2006·Medical Physics·Shalini GuptaMia K Markey
Sep 13, 2006·Medical Physics·Jonathan L JesneckJoseph Y Lo
Dec 13, 2006·Medical Physics·David M CatariousCarey E Floyd
Mar 29, 2007·Medical Physics·Piotr A HabasGeorgia D Tourassi
Dec 13, 2007·Medical Physics·Alfonso Rojas Domínguez, Asoke K Nandi
Jul 25, 2008·Medical Physics·Benjamin J PollardEhsan Samei
Dec 17, 2010·Medical Physics·Georgia D TourassiElizabeth A Krupinski
Feb 1, 2014·Computers in Biology and Medicine·Pedro H BugattiAgma J M Traina
Sep 22, 2006·Current Opinion in Oncology·Chantal Van OngevalAndré Van Steen
Apr 15, 2008·International Journal of Radiation Oncology, Biology, Physics·Kevin LinLawrence W Bassett
Nov 1, 2015·Breast Cancer Research and Treatment·Anna M ChiarelliMartin J Yaffe
Jan 28, 2009·Journal of the American Geriatrics Society·Arash NaeimDavid B Reuben
Apr 4, 2007·Physics in Medicine and Biology·I A ElbakriQuanren Xiong
Mar 30, 2007·Journal of Digital Imaging·Shani RossJianchao Zeng
Aug 27, 2009·Journal of Digital Imaging·Gautam S MuralidharMia K Markey
Aug 24, 2006·Expert Review of Anticancer Therapy·Sarah J StorrJohn F R Robertson
Jan 25, 2008·Journal of Digital Imaging·Denise GuliatoRobson C Soares
Apr 22, 2008·Journal of Digital Imaging·Denise GuliatoTúlio A A Macedo
Mar 31, 2010·Journal of Digital Imaging·Ryohei NakayamaKunio Doi
Oct 12, 2011·International Journal of Computer Assisted Radiology and Surgery·Arianna Mencattini, Marcello Salmeri
Jun 25, 2019·Journal of the National Cancer Institute·Anna M ChiarelliDerek Muradali
Apr 12, 2011·Journal of Surgical Oncology·Mack RoachRonald Gottlieb

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.